Literature DB >> 11872666

Peroxisomal proliferator-activated receptor-gamma upregulates glucokinase gene expression in beta-cells.

Ha-il Kim1, Ji-Young Cha, So-Youn Kim, Jae-woo Kim, Kyung Jin Roh, Je-Kyung Seong, Nam Taek Lee, Kang-Yell Choi, Kyung-Sup Kim, Yong-ho Ahn.   

Abstract

Thiazolidinediones, synthetic ligands of peroxisomal proliferator-activated receptor-gamma (PPAR-gamma), improve peripheral insulin sensitivity and glucose-stimulated insulin secretion in pancreatic beta-cells. To explore the role of PPAR-gamma in glucose sensing of beta-cells, we have dissected the beta-cell-specific glucokinase (betaGK) promoter, which constitutes glucose-sensing apparatus in pancreatic beta-cells, and identified a peroxisomal proliferator response element (PPRE) in the promoter. The betaGK-PPRE is located in the region between +47 and +68 bp. PPAR-gamma/retinoid X receptor-alpha heterodimer binds to the element and activates the betaGK promoter. The betaGK promoter lacking or having mutations in PPRE cannot be activated by PPAR-gamma. PPAR-gamma activates the betaGK promoter in beta-cells as well as non-beta-cells. Furthermore, troglitazone increases endogenous GK expression and its enzyme activity in beta-cell lines. These results indicate that PPAR-gamma can regulate GK expression in beta-cells. Taking these results together with our previous work, we conclude that PPAR-gamma regulates gene expression of glucose-sensing apparatus and thereby improves glucose-sensing ability of beta-cells, contributing to the restoration of beta-cell function in type 2 diabetic subjects by troglitazone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872666     DOI: 10.2337/diabetes.51.3.676

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  26 in total

1.  Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets.

Authors:  Hannah J Welters; Abdelfattah El Ouaamari; Dan Kawamori; John Meyer; Jiang Hu; David M Smith; Rohit N Kulkarni
Journal:  Endocrinology       Date:  2012-07-17       Impact factor: 4.736

2.  Temporal characterization of β cell-adaptive and -maladaptive mechanisms during chronic high-fat feeding in C57BL/6NTac mice.

Authors:  Dhananjay Gupta; Thomas L Jetton; Kyla LaRock; Navjot Monga; Basanthi Satish; James Lausier; Mina Peshavaria; Jack L Leahy
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

Review 3.  Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure.

Authors:  J R Porter; T G Barrett
Journal:  J Med Genet       Date:  2005-03-16       Impact factor: 6.318

Review 4.  Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.

Authors:  S Giannini; M Serio; A Galli
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

5.  Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules.

Authors:  S Schinner; F Ulgen; C Papewalis; M Schott; A Woelk; A Vidal-Puig; W A Scherbaum
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

6.  Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.

Authors:  Evan D Rosen; Rohit N Kulkarni; Pasha Sarraf; Umut Ozcan; Terumasa Okada; Chung-Hsin Hsu; Daniel Eisenman; Mark A Magnuson; Frank J Gonzalez; C Ronald Kahn; Bruce M Spiegelman
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome.

Authors:  Gema Medina-Gomez; Laxman Yetukuri; Vidya Velagapudi; Mark Campbell; Margaret Blount; Mercedes Jimenez-Linan; Manuel Ros; Matej Oresic; Antonio Vidal-Puig
Journal:  Dis Model Mech       Date:  2009-10-19       Impact factor: 5.758

8.  Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver.

Authors:  Tae-Hyun Kim; Hail Kim; Joo-Man Park; Seung-Soon Im; Jin-Sik Bae; Mi-Young Kim; Ho-Geun Yoon; Ji-Young Cha; Kyung-Sup Kim; Yong-Ho Ahn
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

9.  Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).

Authors:  Frédérique Diraison; Laura Parton; Pascal Ferré; Fabienne Foufelle; Celia P Briscoe; Isabelle Leclerc; Guy A Rutter
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

10.  Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.

Authors:  S Schinner; R Krätzner; D Baun; C Dickel; R Blume; E Oetjen
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.